WhiteOak Capital Pharma and Healthcare Fund Direct Growth
NAV as on 28-03-2025
₹ 13
Inception Returns
25.9%
/yr
Historical NAV & Returns
About WhiteOak Capital Pharma and Healthcare Fund Direct Growth
WhiteOak Capital Pharma and Healthcare Fund Direct Growth is an equity fund. This fund was started on 6 February, 2024. The fund is managed by Piyush Baranwal. The fund could potentially beat inflation in the long-run.
Key Parameters
- WhiteOak Capital Pharma and Healthcare Fund Direct Growth has ₹271 Cr worth of assets under management (AUM) as on Feb 2025 and is less than category average.
- The fund has an expense ratio 0.7.
Returns
WhiteOak Capital Pharma and Healthcare Fund Direct Growth has given a CAGR return of 25.91% since inception. Over the last 1 year the fund has given a CAGR return of 30.21%.
Holdings
WhiteOak Capital Pharma and Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials, Industrial. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Max Healthcare Institute Ltd Ordinary Shares, Divi's Laboratories Ltd, Lupin Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
Investment objective of WhiteOak Capital Pharma and Healthcare Fund Direct Growth
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 500.00 and for SIP is INR 100.00. WhiteOak Capital Pharma and Healthcare Fund Direct Growth has no lock in period.
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Overview
| Expense ratio | 0.72% |
Benchmark | S&P BSE Healthcare PR |
| AUM | ₹271 Cr |
| Inception Date | 6 February, 2024 |
| Min Lumpsum/SIP | ₹500/₹100 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 73.27% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
Trailing Returns
as on (28-Mar-25)
Fund Distribution
as on (28-Feb-25)
- AUM of the fund stands at 271.4 Cr as of Feb'25
- AUM decreased by 11.3 Cr between Feb'25 and Jan'25
Top 3 Sectors in February were Health, Basic Materials & Financial Services
Top Growth Drivers | 1M Return |
|---|---|
 Glaxosmithkline Pharmaceuticals Ltd | 14.3% |
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Highlights
Very High Risk
About the fund
Fund Allocations
AUM size ₹271 Cr
Expense Ratio 0.72%
More funds from WhiteOak
WhiteOak Capital Flexi Cap Fund Direct Growth
1Y CAGR
▲ 12.90
WhiteOak Capital Mid Cap Fund Direct Growth
1Y CAGR
▲ 15.12
WhiteOak Capital ELSS Tax Saver Fund Direct Growth
1Y CAGR
▲ 16.29
WhiteOak Capital Large Cap Fund Direct Growth
1Y CAGR
▲ 11.93
WhiteOak Capital Multi Cap Fund Direct Growth
1Y CAGR
▲ 14.42
Frequently Asked Questions for WhiteOak Capital Pharma and Healthcare Fund Direct Growth
WhiteOak Capital Pharma and Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 8.92% | 8.92% |
6 Month Returns | -1.43% | -1.43% |
1 Year Returns | 30.21% | 30.21% |
3 Years Returns | 0% | 0% |
5 Years Returns | 0% | 0% |
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
WhiteOak Capital Pharma and Healthcare Fund Direct Growth | 7.32 | - | - |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
WhiteOak Capital Pharma and Healthcare Fund Direct Growth | 1.02 | - | - |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
WhiteOak Capital Pharma and Healthcare Fund Direct Growth | 0.56 | - | - |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
WhiteOak Capital Pharma and Healthcare Fund Direct Growth | 19.41 | - | - |